Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Genet Med. 2017 Sep 21;20(4):428–434. doi: 10.1038/gim.2017.118

Figure 4. Costs of BRCA test and subtypes, MarketScan CCAE databases, 2003–2014.

Figure 4.

A. Total payment to provider amount per enrollee for BRCA test and subtypes, and percentage of enrollees with zero out-of-pocket payment for any BRCA test (right axis). Subtypes include full-gene sequencing, known variant, Ashkenazi panel and large rearrangement tests. B. Percentage of zero OOP payment among women by diagnosis group: family history of breast or ovarian cancer, newly diagnosed breast or ovarian cancer (incident), previously diagnosed breast or ovarian cancer (non-incident), other.